Global Intragastric Balloon Market

Global Intragastric Balloon Market size was valued at USD 59.55 Mn in 2024 and the Global Intragastric Balloon Market revenue is expected to grow by 14.45% from 2025 to 2032, reaching nearly USD 175.31 Mn by 2032, fuelled by rising obesity rates, minimally invasive demand, and technological advancements in weight-loss solutions.

Intragastric Balloon Market Overview

An intragastric balloon is a medical device designed for weight loss by temporarily altering the stomach's capacity. Typically made of silicone, it is introduced into the stomach through an endoscopic procedure, where it is initially deflated and then filled with either saline solution or gas. Its primary purpose is to induce weight loss by reducing the amount of food an individual consume during a meal due to the balloon occupying space in the stomach, thereby promoting early satiety. Intragastric balloons are commonly recommended for individuals who are obese or significantly overweight and have struggled to achieve substantial weight loss through conventional methods like diet and exercise. They offer a non-surgical approach to weight management, making them less invasive and requiring a shorter recovery period compared to traditional weight loss surgeries like gastric bypass or sleeve gastrectomy.

These balloons are typically utilized as part of a broader weight management program, emphasizing lifestyle changes, healthier eating habits, and increased physical activity. While they lead to weight loss and improvements in various obesity-related health conditions, it's important to note that intragastric balloons are considered a short-term solution. They are typically left in the stomach for a period of six months to a year, after which they are removed. During this time, patients are encouraged to make sustainable lifestyle changes to help maintain their weight loss after the balloon is removed. Eligibility for intragastric balloon insertion is determined by healthcare professionals based on factors such as the individual's overall health, weight, and medical history, as it may not be suitable for everyone. In the United States, individuals with a BMI of 30 or higher, who successfully pass the health evaluation for the procedure, are eligible to receive the intragastric balloon. Those with class III obesity, who meet the criteria for bariatric surgery, have the option to opt for the balloon due to its lower associated risks. Additionally, individuals whose obesity poses a safety concern for surgical intervention consider the balloon as an intermediate step to shed sufficient weight, thus making them eligible for surgery.

To know about the Research Methodology :- Request Free Sample Report

Intragastric Balloon Market Dynamics

Exploring the Role of Intragastric Balloons in Non-Invasive Obesity Management
The increasing prevalence of obesity has become a prominent health concern in recent years, with its detrimental effects on overall well-being and the associated risk of various medical conditions. In response to this growing epidemic, there has been a consistent push in the healthcare industry towards adopting non-invasive methods for obesity management. Among these approaches, intragastric balloons have emerged as a valuable adjunct in the battle against obesity. Intragastric balloons offer a promising solution by providing a less invasive option for weight management. These devices are typically inserted into the stomach through a minimally invasive procedure, offering benefits such as reduced recovery time and a lower risk of complications compared to more invasive surgical options. This non-surgical approach is particularly appealing to individuals who may be hesitant about or ineligible for surgical interventions due to medical conditions or personal preferences.

One of the key factors driving the utilization of intragastric balloons is the promising outcomes they offer, especially when used in conjunction with lifestyle modifications and pharmacotherapy. These balloons facilitate portion control by occupying space in the stomach, leading to reduced food intake and a sense of fullness, which aids in weight loss. When combined with dietary changes, regular physical activity, and, if necessary, medication-based therapies, intragastric balloons significantly enhance the effectiveness of obesity management strategies. These aspects drive the intragastric balloon market growth.

Constraints and Considerations for Intragastric Balloon Usage Hampered the Intragastric Balloon Market Growth

Intragastric balloons offer a non-invasive approach to weight loss, several important considerations act as restraints on their widespread adoption in the weight management market. One significant limitation is their temporary nature. Typically, these balloons are removed after a period ranging from six months to a year, providing only a short-term solution to weight loss. For individuals seeking long-term weight maintenance, additional interventions may be necessary. Moreover, the use of intragastric balloons be accompanied by side effects during the initial weeks after placement, including symptoms like nausea, vomiting, abdominal discomfort, and acid reflux. These side effects are challenging for some patients to tolerate.

Weight regain is another concern associated with intragastric balloons. After their removal, maintaining the lost weight requires a commitment to a healthy lifestyle that includes diet and exercise changes. Failure to make these long-term changes results in the reoccurrence of weight issues. Furthermore, while intragastric balloons lead to weight loss, the extent of this loss varies among individuals and may not be as significant as what is achieved with other bariatric surgeries such as gastric bypass or sleeve gastrectomy. Additionally, there is a rare but potential risk of balloon deflation or migration within the stomach, which may necessitate further medical attention or even surgical removal. These factors restrain the growth of the intragastric balloon market.

Expanding Horizons is a Key Factor for the Growing Opportunity in the Intragastric Balloon Market Demand

The intragastric balloon market presents a significant opportunity in the field of non-surgical weight management, driven by the increasing prevalence of obesity and the growing demand for minimally invasive treatment options. This market is poised for expansion as it addresses key medical, economic, and patient-oriented factors. The rising global obesity epidemic has created a substantial market opportunity for intragastric balloons. As obesity rates continue to soar, healthcare providers and patients alike are seeking effective, less invasive interventions to combat excess weight. Intragastric balloons offer a promising solution, appealing to individuals who may not be candidates for more invasive surgical procedures due to medical contraindications or personal preferences. The economic impact of obesity is substantial, with obesity-related healthcare costs reaching staggering figures. Intragastric balloons provide a cost-effective alternative to long-term obesity management, potentially reducing the burden on healthcare systems by mitigating the need for more costly treatments and interventions associated with obesity-related comorbidities.

The intragastric balloon market benefits from its adaptability as a bridging option for individuals who need to lose weight before undergoing other bariatric surgeries, making it a complementary element in the broader field of weight management. Intragastric balloons are not only minimally invasive but also offer relatively short recovery times, making them appealing to patients seeking a quicker return to their daily lives compared to traditional surgical approaches. Their potential for achieving substantial weight loss, when combined with lifestyle modifications, appeals to individuals who desire tangible results. As the market continues to evolve, innovations in balloon design and materials, enhanced patient selection criteria, and improved post-procedural support systems are expected to contribute to the growth of this market. Additionally, the possibility of insurance coverage expansion for intragastric balloon procedures further increases market accessibility. All these aspects boost the market intragastric balloon market demand during the forecast period.

The State of Obesity 2022 report highlights a concerning trend where nearly four out of ten American adults are grappling with obesity, and these rates are steadily rising across different demographics. This emphasizes that obesity is a complex issue influenced by a multitude of factors, including societal, biological, genetic, and environmental elements, many of which are beyond an individual's control. According to the report's authors, effectively addressing the obesity crisis will necessitate a focus on economic and structural factors that impact people's living conditions. Intragastric balloons are a valuable tool in the fight against obesity. While the report underscores the multifaceted nature of obesity, intragastric balloons offer a practical solution for individuals struggling with excess weight.

These devices provide a non-surgical option for weight loss, which is especially important in a context where obesity rates are on the rise. Intragastric balloons help individuals control their appetite and reduce food intake, serving as an effective tool for weight management. They work by physically occupying space in the stomach, leading to feelings of fullness even with smaller meals. This be particularly beneficial for those facing challenges related to genetic predisposition or environmental factors that contribute to obesity. Moreover, intragastric balloons are a non-invasive approach, which aligns with the recognition in the report that obesity is influenced by societal and structural factors. Individuals who may not have access to or prefer not to undergo traditional weight loss surgeries consider intragastric balloons as a safer and more accessible option.

Global Intragastric Balloon Market Segment Analysis

Based on Product, Global Intragastric Balloon Market is Segmented into Single Balloon, Dual Balloon and Triple Balloon. In 2024, the single balloon segment dominated the global intragastric balloon market, accounting for the largest revenue share due to its proven efficacy, lower procedural complexity, and wider clinical adoption. Single-balloon systems are preferred by physicians and patients alike for their simpler insertion process, reduced risk of complications, and cost-effectiveness compared to dual or triple balloon alternatives. Their established safety profile and strong clinical validation for moderate weight loss (typically 10-15% of total body weight) make them the first-line choice in many bariatric clinics.

Based on Filling Material, Global Intragastric Balloon Market is Segmented into Saline-Filled and Gas-Filled. In 2024, the saline-filled segment dominated the global intragastric balloon market, holding the largest market share due to its proven safety profile, clinical reliability, and widespread physician preference. Saline-filled balloons are favoured for their controllable inflation process, lower risk of complications (such as leaks or ruptures), and adjustable volume, which allows for personalized patient treatment. Their longer track record in bariatric practice compared to gas-filled alternatives has led to greater trust among healthcare providers, while their cost-effectiveness and compatibility with existing endoscopic procedures further drive adoption.

Intragastric Balloon Market Regional Insights

North America dominates the global intragastric balloon market, with the highest revenue share in 2022. Several factors contribute to this market's growth in the region. The increasing prevalence of obesity is set to be a key driver of growth in the intragastric balloon market in the foreseeable future. For instance, the National Institute of Health (NIH) reports that obesity, along with being overweight, ranks as the second leading cause of preventable deaths in the United States. The surge in the adoption of unhealthy dietary patterns and sedentary lifestyles, characterized by a lack of physical activity, is primarily responsible for the widespread occurrence of obesity on a global scale.

Consequently, the escalating instances of obesity exert significant pressure on healthcare resources, ultimately fostering the expansion of the intragastric balloon industry. Furthermore, the increasing awareness surrounding obesity and its associated health complications is poised to have a profound impact on the demand for and adoption of intragastric balloons in the coming years. Many countries are grappling with a substantial rise in the economic burden imposed by this disease. Consequently, numerous nations are taking proactive initiatives to control and manage obesity comprehensively. These efforts contribute to the dissemination of knowledge concerning obesity management and the availability of various weight control alternatives, including intragastric balloons, thus fuelling intragastric balloon market growth throughout the forecast period in North America.

Latest Development

In September 2022, for intragastric balloons market witnessed a significant development with the launch of Allurion's innovative swallowable gastric balloon capsule for weight loss in India. This strategic move by Allurion has redefined the competitive landscape in the industry. Allurion's comprehensive weight loss program not only includes the groundbreaking Swallowable Capsule but also integrates a suite of technology-driven solutions designed to enhance the patient experience and outcomes.

Allurion introduced its Swallowable Gastric Balloon Capsule for weight loss in the Indian market, marking a pivotal moment in the field of non-surgical weight management. This product launch signifies a bold step in expanding the global footprint of intragastric balloons and reinforces Allurion's commitment to addressing the escalating obesity concerns in India, which is home to one of the world's largest populations. In addition to the innovative Swallowable Capsule, they introduced the Allurion Virtual Care Suite, a cutting-edge remote patient monitoring solution powered by the Allurion Iris AI platform. This suite encompasses a range of digital tools and devices, including the Allurion Mobile App, Connected Scale, and Health Tracker.

These components synergize to provide patients with a comprehensive and personalized weight management experience, enabling them to track their progress, receive guidance, and stay connected with healthcare professionals throughout their weight loss journey. The introduction of Allurion's innovative products and services into the Indian market is set to intensify competition in the intragastric balloon sector. It highlights the industry's dedication to innovation and patient-centric care, ultimately providing individuals with a wider array of choices for their weight loss journeys. Allurion's holistic approach may serve as a benchmark for future developments in the field, encouraging further advancements and ensuring that patients have access to more effective and personalized solutions for obesity management for the Intragastric Balloon market demand.

Intragastric Balloon Market Scope: Inquiry Before Buying

Intragastric Balloon Market Regional Insights:

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Intragastric Balloon Market Key Players:

1. Obalon Therapeutics (U.S.)
2. Apollo Endosurgery Inc. (U.S.)
3. Allurion (U.S.)
4. Spatz3 (U.S.)
5. ReShape Lifesciences Inc.v (U.S.)
6. Helioscopie (France)
7. Apollo Endosurgery, Inc. (U.S.)
8. Obalon Therapeutics, Inc. (U.S.)
9. Endalis (France)
10. Lexel Medical (U.S.)
11. Districlass Medical (France)
12. Shandong Institute of Medical Instruments (China)
13. Phagia Technologies, Inc. (U.S.)
14. Fengh Medical B.V. (China)
15. Medicone Group (U.S.)
16. BAROnova Inc. (U.K.)

FAQs:

1. Which region has the largest share in Global Intragastric Balloon Market?
Ans: North America region held the highest share in 2024.

2. What is the growth rate of Market?
Ans: The Global Intragastric Balloon Market is growing at a CAGR of 14.45% during forecasting period 2025-2032.

3. What is scope of the Global market report?
Ans: Global Intragastric Balloon Market report helps with the PESTEL, PORTER, COVID-19 impact analysis, recommendations for investors and leaders, and market estimation of the forecast period.

4. Who are the key players in Global Intragastric Balloon Market?
Ans: The important key players in the Global Intragastric Balloon Market are Apollo Endosurgery, Allurion Technologies, Lexal Srl and Districlass Medical SA.

5. What is the study period of this Global Intragastric Balloon Market?
Ans: Global Intragastric Balloon Market is studied from 2025 to 2032.